36
        
        
          |
        
        
          Volume2 Issue3
        
        
          I
        
        
          ssues and
        
        
          P
        
        
          eople
        
        
          Dr. Almeidawas indental schoolwhenher father
        
        
          encouragedher topursuedental sleepmedicine; itwas the
        
        
          start of a lifelong interest in the treatment of sleep-related
        
        
          breathingdisorders. “He sawadentist givea talkabout
        
        
          treatment for sleepapneaand toldme, ‘Youneed todo
        
        
          thisbecausemypatientsneedhelp.’” She isnowa leader
        
        
          inher field—a renowned researcher; assistant professor
        
        
          in theUniversityof BritishColumbia (UBC) department
        
        
          of oral health sciences; andamember of theUBCSleep
        
        
          Team, amultidisciplinarygroupdedicated to researching
        
        
          respiratory sleepdisorders. Shealsopractises at her dental
        
        
          sleepmedicineclinic inVancouver and isoneof 16Canadian
        
        
          dentistswithDiplomate statusgrantedby theAmerican
        
        
          BoardofDental SleepMedicine.
        
        
          An alternative to the
        
        
          gold standard treatment
        
        
          Obstructive sleepapnea is adisorder thatmayaffect
        
        
          over 1 in4Canadianadults, but is self-reportedbyonly
        
        
          3%of Canadians.
        
        
          1
        
        
          Thegold standard forOSA treatment
        
        
          is continuouspositiveairwaypressure (CPAP), but the
        
        
          treatment doesnotwork for everyone. Dr. Almeidaexplains,
        
        
          “CPAP is themost effective treatment, short term. But
        
        
          compliance is an issue.We know thatmanypatients find the
        
        
          maskor the treatment, ingeneral, uncomfortable.
        
        
          Theymight take themaskoff in themiddle
        
        
          of thenight or theyonlyuse it a few times
        
        
          aweek. Goodadherence toCPAP isoften
        
        
          describedas 5days/week, 70%of the
        
        
          night, and following this criteriaabout
        
        
          40–60%of thepatientsusingCPAPare
        
        
          thought toexhibit goodadherence.”
        
        
          For patientswhoareunable
        
        
          to tolerateCPAPor use it
        
        
          inconsistently, analternative
        
        
          treatment forOSA is anoral appliance—dental orthotics,
        
        
          tongue retainingdevices,mandibular advancement
        
        
          appliances (MAA) ormandibular advancement devices
        
        
          (MAD). According to theCanadianThoracicSocietyand the
        
        
          AmericanAcademyof SleepMedicine, oral appliances are
        
        
          recommendedas thefirst treatment for patientswho snore
        
        
          (without apnea) orwhohavemild tomoderateOSA. Oral
        
        
          appliances arealsoanoption for patientswith severeOSA
        
        
          whofind it difficult to stickwithCPAP therapy.
        
        
          “Whenwecompare themain treatment for sleepapnea,
        
        
          which is theCPAP, toanoral appliance, theCPAP ismore
        
        
          effective in the reductionof theapneasover the short term,”
        
        
          explainsDr. Almeida. “But new studieson severecasesof
        
        
          OSAare showing that the long-termeffectivenessof CPAP
        
        
          andanoral appliance is about the samebecausepatients are
        
        
          more likely touse theoral appliance throughout thenight.”
        
        
          2, 3
        
        
          Althoughoral appliancesdon’twork for all patients, Dr.
        
        
          Almeida says that roughly two-thirdsof patientsbenefit
        
        
          therapeutically from them.
        
        
          4
        
        
          Inher experience, shefinds
        
        
          medical professionals are “still very skeptical about oral
        
        
          appliances for treatingOSA, in regards to treatment
        
        
          outcomes. It’s anareawhere there is still a lackof extensive
        
        
          evidenceon the treatment’s long-termeffectiveness,which
        
        
          considersbothefficacyandadherence to treatment.”
        
        
          Formore informationon thedentist’s role in themanagement
        
        
          of snoringandOSA, refer to theCollegeofDentalSurgeonsof
        
        
          BritishColumbiadocument, “ObstructiveSleepApnea,TheRole
        
        
          ofDentists in theTreatmentofSnoringandObstructiveSleep
        
        
          ApneawithOralAppliances.”
        
        
          6
        
        
        
          Dr. Almeidacreditsher father's
        
        
          influenceonher careerpath.
        
        
          The inauguralORANGE (OralApplianceNetworkonGlobal
        
        
          Effectiveness) networkmeeting in2012.